Cross‐Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications
Min Xing, Chang Zhou, Yi Tang, Shuhui Xu, Shasha Zhou, Weiai Liu et al. Cross‐Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications. // International Journal of Cancer. – 2026. – DOI: 10.1002/ijc.70704. – URL: https://onlinelibrary.wiley.com/doi/10.1002/ijc.70704?af=R
Min Xing, Chang Zhou, Yi Tang, Shuhui Xu, Shasha Zhou, Weiai Liu, & Huiping Liu (2026). Cross‐Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications. International Journal of Cancer. https://doi.org/10.1002/ijc.70704
Min Xing, et al. “Cross‐Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications.” International Journal of Cancer, 2026. doi:10.1002/ijc.70704.
@article{Xing2026,
title = {Cross‐Regulation Between DNA Methylation and Circadian Clock Reprogramming in Ovarian Cancer: Mechanistic Insights, Biomarker Potential, and Therapeutic Implications},
author = {Xing, Min and Zhou, Chang and Tang, Yi and Xu, Shuhui and Zhou, Shasha and Liu, Weiai and Liu, Huiping},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70704},
url = {https://onlinelibrary.wiley.com/doi/10.1002/ijc.70704?af=R}
}